High‐dose non‐sedating antihistamines are used insufficiently in chronic urticaria patients treated with omalizumab
Abstract Background The lifetime prevalence of chronic urticaria (CU) is 0.5%–1%. In some patients with CU, symptomatic control is not achieved with non‐sedating second‐generation H1 antihistamines (nsAH1) alone, even with quadrupled standard doses as recommended in international guidelines. In thes...
Na minha lista:
| Principais autores: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wiley
2021-12-01
|
| coleção: | Clinical and Translational Allergy |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1002/clt2.12085 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|